Parasympathetic Blockade Attenuates Augmented Pancreatic Polypeptide but Not Insulin Secretion in Pima Indians

Diabetes

Volumn 53, Issue 3, 2004, Pages 663-671

  De Courten, Barbora Vozarova ^a   Weyer, Christian ^a   Stefan, Norbert ^a   Horton, Mark ^b   DelParigi, Angelo ^a   Havel, Peter ^c   Bogardus, Clifton ^a   Tataranni, P Antonio ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PHOENIX INDIAN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; GLUCOSE; INSULIN; PANCREAS POLYPEPTIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE INTAKE; CAUCASIAN; CHOLINERGIC RECEPTOR BLOCKING; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG INFUSION; ETHNIC DIFFERENCE; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; INDIAN; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN INTAKE; STOMACH EMPTYING; VAGUS NERVE STIMULATION;

ADULT; ARIZONA; ATROPINE; BLOOD GLUCOSE; BODY CONSTITUTION; DIABETES MELLITUS, TYPE 2; DIASTOLE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GLUCOSE TOLERANCE TEST; HAND STRENGTH; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; PANCREATIC POLYPEPTIDE; SYSTOLE; VAGUS NERVE;

EID: 1442276959     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.3.663     Document Type: Article

References (32)

1. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH: Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113:144-156, 1981
2. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C: Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876, 1991
3. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
4. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356-1359, 1989
5. Weyer C, Hanson R, Tataranni PA, Bogardus C, Pratley RE: A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49:2094-2101, 2000
6. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E: Risk factors for NIDDM in white population: Paris Prospective Study. Diabetes 40:796-799, 1991
7. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenstrom J: Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabet Med 7:407-413, 1990
8. Pettitt DJ, Moll PP, Knowler WC, Mott DM, Nelson RG, Saad MF, Bennett PH, Kottke BA: Insulinemia in children at low and high risk of NIDDM. Diabetes Care 16:608-615, 1993
9. Fukudo S, Virnelli S, Kuhn CM, Cochrane C, Feinglos MN, Surwit RS: Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice. Diabetes 38:1433-1438, 1989
10. Fletcher JM, McKenzie N: The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese (fa/fa) Zucker rat. J Endocrinol 118:87-92, 1988
11. Rohner-Jeanrenaud F, Ionescu E, Jeanrenaud B: The origins and role of efferent vagal nuclei in hyperinsulinemia in hypothalamic and genetically obese rodents. J Auton Nerv Syst 9:173-184, 1983
12. Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, Jeanrenaud B: Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40:1269-1277, 1997
13. Berthoud H, Jeanrenaud B: Acute hyperinsulinemia and its reversal by vagotomy after lessons of the ventromedial hypothalamus in anaestetized rats. Endocrinology 105:146-151, 1979
14. Gingerich RL, Nagulesparan M, Bennion L, Dye ES, Bauman WA: Pancreatic polypeptide in Pima Indians: the influence of obesity and diabetes. Metabolism 34:25-29, 1985
15. Weyer C, Salbe AD, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA: Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 50:223-230, 2001
16. Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, de Muckadell OB, Stadil F: Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61:781-789, 1978
17. Schwartz TW, Rehfeld JF, Stadil F, Larson LI, Chance RE, Moon N: Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet 1:1102-1105, 1976
18. Feldman M, Richardson CT, Taylor IL, Walsh JH: Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J Clin Invest 63:294-298, 1979
19. Tappy L, Chiolero R, Randin JP, Burckhardt P, Felber JP: Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects. Horm Metab Res 18:821-826, 1986
20. Del Rio G, Procopio M, Bondi M, Marrama P, Menozzi R, Oleandri SE, Grottoli S, Maccario M, Velardo A, Ghigo E: Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord 21:1111-1114, 1997
21. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser. no. 17)
22. Tataranni PA, Ravussin E: Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730-734, 1995
23. Rossi M, Marti G, Ricordi L, Fornasari G, Finardi G, Fratino P, Bernardi L: Cardiac autonomic dysfunction in obese subjects. Clin Sci (Lond) 76:567-572, 1989
24. Medhus AW, Lofthus CM, Bredesen J, Husebye E: Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil 13:179-185, 2001
25. Medhus AW, Sandstad O, Bredesen J, Husebye E: Delay of gastric emptying by duodenal intubation: sensitive measurement of gastric emptying by the paracetamol absorption test. Aliment Pharmacol Ther 13:609-620, 1999
26. Festa A, D'Agostino RJ, Mykkanen L, Tracy RP, Zaccaro D, Hales C: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance: the Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 19:562-568, 1999
27. Watson GS, Peskind ER, Asthana S, Puganan K, Wait C, Chapman D, Schwartz MW, Plymate S, Craft S: Insulin increases CSF Abeta42 levels in normal older adults. Neurology 60:1899-1903, 2003
28. D'Alessio DA, Kieffer TJ, Taborsky GJ Jr, Havel PJ: Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 86:1253-1259, 2001
29. Teff KL, Townsend RR: Early phase insulin infusion and muscarinic blockade in obese and lean subjects. Am J Physiol 277:R198-R208, 1999
30. Ahren B, Holst JJ: The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50:1030-1038, 2001
31. Benthem L, Mundinger TO, Taborsky GJ Jr: Meal-induced insulin secretion in dogs is mediated by both branches of the autonomic nervous system. Am J Physiol Endocrinol Metab 278: E603-E610, 2000
32. Kelly J: Principles of the functional and anatomical organisation of the nervous system. In Principles of Neural Science. Kandel ER, Schwartz JH, Eds. San Diego, CA, Elsevier Press, 1985, p. 211-221